King Carolyn G, Kobayashi Takashi, Cejas Pedro J, Kim Taesoo, Yoon Kwiyeom, Kim Gregory K, Chiffoleau Elise, Hickman Somia P, Walsh Patrick T, Turka Laurence A, Choi Yongwon
Department of Pathology and Laboratory Medicine, Abramson Family Cancer Research Institute, Philadelphia, Pennsylvania 19104, USA.
Nat Med. 2006 Sep;12(9):1088-92. doi: 10.1038/nm1449. Epub 2006 Jul 20.
TRAF6 has a key role in the regulation of innate immune responses by mediating signals from both TNF receptor and interleukin-1 receptor/Toll-like receptor superfamilies. Here we show that T cell-specific deletion of TRAF6 unexpectedly results in multiorgan inflammatory disease. TRAF6-deficient T cells exhibit hyperactivation of the phosphatidylinositol 3-kinase (PI3K)-Akt pathway compared with wild-type T cells and, as a result, become resistant to suppression by CD4+ CD25+ regulatory T cells. These data identify a previously unrecognized role for TRAF6 in the maintenance of peripheral tolerance, and suggest the presence of a T cell-intrinsic control mechanism to render responder T cells susceptible to tolerizing signals.
TRAF6通过介导来自肿瘤坏死因子受体和白细胞介素-1受体/Toll样受体超家族的信号,在先天免疫反应的调节中发挥关键作用。在此我们表明,T细胞特异性缺失TRAF6意外地导致多器官炎症性疾病。与野生型T细胞相比,缺乏TRAF6的T细胞表现出磷脂酰肌醇3激酶(PI3K)-Akt途径的过度激活,因此对CD4+CD25+调节性T细胞的抑制产生抗性。这些数据确定了TRAF6在维持外周耐受性方面以前未被认识的作用,并提示存在一种T细胞内在控制机制,使反应性T细胞易受耐受信号的影响。